Publication-ready workflow for Mycobacterium tuberculosis RecA inhibitor discovery using QSAR, machine learning, Bayesian classification, FDA drug repurposing, and molecular docking.
machine-learning bioinformatics computational-chemistry drug-discovery chemoinformatics tuberculosis qsar molecular-docking reca bayesian-classification
-
Updated
May 30, 2026 - Jupyter Notebook